These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Progastrin-releasing peptide: stability in plasma/serum and upper reference limit.
    Author: Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E.
    Journal: Tumour Biol; 2008; 29(3):204-10. PubMed ID: 18667845.
    Abstract:
    BACKGROUND: Progastrin-releasing peptide (proGRP) is a promising tumor marker for small cell lung cancer (SCLC). Here we study the stability of proGRP in serum and plasma, as well as proGRP levels in healthy individuals, to provide a framework for clinical studies. METHODS: Serum, with and without protease inhibitors, and plasma from SCLC patients and healthy individuals were assayed for proGRP immediately after collection and following various storage conditions. RESULTS: No degradation was observed in serum or plasma after storage for 4 weeks at -30 degrees C. Serum proGRP levels were stable for up to 3 days at 4 degrees C, but decreased at room temperature. Addition of protease inhibitors to patient serum did not markedly improve stability. In EDTA plasma, proGRP concentrations increased upon storage in some samples at room temperature and 4 degrees C. When assayed immediately after collection, no significant variations in proGRP concentrations were observed between serum and EDTA plasma (n = 171). A 97.5-percentile reference limit of 58.9 ng/l was calculated from data from 806 individuals. However, proGRP levels were significantly correlated with age, sex, creatinine concentrations, body mass index and smoking. CONCLUSION: Serum is the preferred material for measuring proGRP, provided it is stored at 4 degrees C and assayed within 3 days.
    [Abstract] [Full Text] [Related] [New Search]